Caribou Biosciences (CRBU) Long-Term Investments (2021 - 2026)

Caribou Biosciences (CRBU) has 6 years of Long-Term Investments data on file, last reported at $1.0 million in Q1 2026.

• Long-Term Investments for Q1 2026 came in at $1.0 million, down 74.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (down 74.89% YoY), and the FY2025 annual result was $3.5 million, down 91.2% from the prior year.
• Long-Term Investments fell to $1.0 million in Q1 2026 per CRBU's latest filing, from $3.5 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $69.4 million in Q4 2022 and troughed at $132000.0 in Q2 2025.
• A 5-year average of $15.8 million and a median of $7.8 million in 2023 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2024 and 2025: Long-Term Investments soared 545.43% in 2024, then sank 99.74% in 2025.
• A 5-year view of Long-Term Investments shows it stood at $69.4 million in 2022, then plunged by 88.82% to $7.8 million in 2023, then jumped by 413.98% to $39.8 million in 2024, then plunged by 91.2% to $3.5 million in 2025, then tumbled by 71.44% to $1.0 million in 2026.
• Business Quant data shows CRBU's Long-Term Investments at $1.0 million in Q1 2026, $3.5 million in Q4 2025, and $143000.0 in Q3 2025.